VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 111 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $306,722 | -45.8% | 71,000 | -14.8% | 0.00% | – |
Q2 2023 | $565,669 | 0.0% | 83,309 | 0.0% | 0.00% | – |
Q1 2023 | $565,669 | +27.3% | 83,309 | +38.5% | 0.00% | – |
Q4 2022 | $444,509 | -99.9% | 60,150 | 0.0% | 0.00% | – |
Q3 2022 | $594,280,000 | -9.4% | 60,150 | 0.0% | 0.00% | – |
Q2 2022 | $655,635,000 | -3.6% | 60,150 | 0.0% | 0.00% | – |
Q1 2022 | $680,295,000 | -27.9% | 60,150 | 0.0% | 0.00% | – |
Q4 2021 | $943,755,000 | -8.5% | 60,150 | 0.0% | 0.00% | – |
Q3 2021 | $1,030,970,000 | +0.2% | 60,150 | +25.7% | 0.00% | – |
Q2 2021 | $1,029,060,000 | +66.1% | 47,841 | +16.0% | 0.00% | – |
Q1 2021 | $619,709,000 | -1.4% | 41,259 | -13.8% | 0.00% | – |
Q4 2020 | $628,750,000 | +36.0% | 47,850 | 0.0% | 0.00% | – |
Q3 2020 | $462,232,000 | -15.6% | 47,850 | 0.0% | 0.00% | – |
Q2 2020 | $547,404,000 | +17.3% | 47,850 | +6.2% | 0.00% | – |
Q1 2020 | $466,573,000 | -28.5% | 45,036 | +13.3% | 0.00% | – |
Q4 2019 | $652,183,000 | +10.0% | 39,743 | -11.0% | 0.00% | – |
Q3 2019 | $593,033,000 | +22.6% | 44,656 | +30.1% | 0.00% | – |
Q2 2019 | $483,667,000 | +44.8% | 34,327 | +89.1% | 0.00% | – |
Q1 2019 | $334,070,000 | -4.8% | 18,156 | +35.3% | 0.00% | – |
Q4 2018 | $350,769,000 | +129335.1% | 13,424 | -17.6% | 0.00% | – |
Q3 2016 | $271,000 | +48.9% | 16,300 | 0.0% | 0.00% | – |
Q2 2016 | $182,000 | +48.0% | 16,300 | +10.9% | 0.00% | – |
Q1 2016 | $123,000 | -56.5% | 14,700 | -51.6% | 0.00% | – |
Q4 2015 | $283,000 | -20.9% | 30,400 | -4.4% | 0.00% | – |
Q3 2015 | $358,000 | -5.5% | 31,800 | +6.4% | 0.00% | – |
Q2 2015 | $379,000 | +43.0% | 29,900 | +4.9% | 0.00% | – |
Q1 2015 | $265,000 | -32.7% | 28,500 | +3.6% | 0.00% | – |
Q4 2014 | $394,000 | +217.7% | 27,500 | +131.1% | 0.00% | – |
Q3 2014 | $124,000 | -35.8% | 11,900 | 0.0% | 0.00% | – |
Q2 2014 | $193,000 | – | 11,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |